PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 28, 2026Laboratory Medicine0 citations

Approach to hyponatremia: the value of fractional excretion of uric acid and phosphate

View Full Paper
BABeatriz Izquierdo AlarcónCPCarlos Castillo PérezPPP. Jurado Parras

Key Points

  • This report aims to differentiate between SIADH and CSWS in a patient with hyponatremia using laboratory values.
  • Case report of a 68-year-old woman with hyponatremia and multiple myeloma.
  • Evaluated biomarkers including uric acid and phosphate fractional excretion.
  • Clinical laboratory tests were conducted to assess levels and guide diagnosis.
  • Initial diagnosis of cerebral salt-wasting syndrome (CSWS) was reconsidered.
  • Final diagnosis established using fractional excretion measurements.
  • Patient exhibited clinical improvement following the correct therapeutic intervention.

Abstract

Abstract Introduction Differentiating syndrome of inappropriate antidiuretic hormone secretion (SIADH) from cerebral salt-wasting syndrome (CSWS) is a major challenge because of the identical clinical parameters that characterize their etiologies. Methods A 68-year-old woman presented to the emergency department with fever, chills, and headache. The patient had a history of multiple myeloma in active follow-up, with no recent chemotherapy treatment. During her hospital stay, the patient developed hypoosmolar hyponatremia. Results Initially, a diagnosis of CWS was made, but the torpid evolution of natremia led to reconsideration of the diagnosis. The use of fractional excretion of uric acid and phosphorus by the clinical laboratory established a definitive diagnosis, and clinical improvement was seen with appropriate therapeutic measures. Discussion This case report highlights the central role of the laboratory in the study of hyponatremia. The joint evaluation of biomarkers such as uric acid, fractional excretion of uric acid, phosphorus, and fractional excretion of phosphate allows for a more accurate differential diagnosis between SIADH and CSWS, overcoming the limitations of the volume approach and thus minimizing the risks associated with invasive or inconclusive therapeutic tests and delays in the implementation of therapeutic measures.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Alarcón et al. (2026) studied this question.

synapsesocial.com/papers/69c7724e8bbfbc51511e2babhttps://doi.org/10.1093/labmed/lmag009
Ask AI
Helpful
Bookmark
Share
View Full Paper